Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY:PFE)

27.58 +0.11 (+0.40%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most ↗
Via MarketBeat
News headline image
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
The global economic landscape has been jolted in the opening weeks of 2026 as the United States government formalizes a series of aggressive 25% tariff proposals targeting the critical sectors of... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
In a dramatic week for the pharmaceutical sector, a stark rift has opened between the two undisputed titans of the weight-loss drug market. On February 4, 2026, Eli Lilly (NYSE:LLY) reported a... 
Via MarketMinute
Topics Earnings Economy
News headline image
Pfizer Maps Post-Covid Reset With Obesity Trials And Deep Cost Cuts ↗
Via Talk Markets
News headline image
Pfizer (PFE) Q4 2024 Earnings Call Transcript ↗
Pfizer (PFE) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Pfizer (PFE) Q3 2024 Earnings Call Transcript ↗
Pfizer (PFE) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Pfizer (PFE) Q2 2025 Earnings Call Transcript ↗
Pfizer (PFE) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗
The medications that will be offered via the platform include Novo Nordisk’s popular weight-loss drug Wegovy, Eli Lilly and Company's Zepbound, Amgen’s cholesterol drug Repatha, and Merck’s diabetes... 
Via Stocktwits
Topics Economy Government World Trade
Pfizer Reports Positive Weight-Loss Trial Results, Strong Q4 – So Why Is PFE Stock Falling? ↗
Via Stocktwits
Pfizer Inc. (NYSE:PFE) Beats Q4 2025 Estimates but Muted Outlook Tempers Investor Reaction ↗
Via Chartmill
News headline image
The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)
As of February 5, 2026, Eli Lilly and Company (NYSE: LLY) stands as a paradigm-shifting titan in the global healthcare landscape. Having recently crossed the historic $1 trillion market capitalization... 
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
Can Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party? ↗
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can. 
Via The Motley Fool
These S&P500 stocks are the most active in today's session ↗
Via Chartmill
News headline image
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
Eli Lilly is riding the GLP-1 gravy train, while this competitor is struggling to get on board. 
Via The Motley Fool
AI Panic Hits Software, PayPal Faceplants, Walmart Joins the $1T Club ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds
Global pharmaceutical company Pfizer (NYSE:PFE) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 1.2% year on year to $17.56 billion. The company expects the full year’s revenue... 
Via StockStory
Topics Intellectual Property
News headline image
Will the Market Crash in 2026? Here's What History Says and What to Do About It ↗
Always be prepared. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
Topics Electric Vehicles
News headline image
Bristol-Myers Squibb Earnings: What To Look For From BMY
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results this Thursday before the bell. Here’s what to expect. 
Via StockStory
News headline image
Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off ↗
The company expects to launch more than 20 pivotal late-stage trials this year. 
Via The Motley Fool
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
Most active stocks in Tuesday's session ↗
Via Chartmill
News headline image
Pfizer (PFE) Q4 2025 Earnings Call Transcript ↗
Pfizer (PFE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Why Pfizer Stock Dropped Today ↗
Is Pfizer stock a buy at under 9x earnings? Yes. It is. 
Via The Motley Fool
Topics Earnings
News headline image
Pfizer&#39;s Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops ↗
Pfizer reported strong mid-stage weight loss trial results for its monthly obesity drug and posted fourth-quarter earnings that beat analyst estimates, signaling progress in its obesity pipeline. 
Via Benzinga
News headline image
Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update ↗
Pfizer stock tumbled early Tuesday after the drugmaker reaffirmed its modest outlook for 2026 and provided an obesity update. 
Via Investor's Business Daily
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.2% year on year to $17.56 billion. The company expects the full year’s revenue... 
Via StockStory
News headline image
Pfizer, Merck And 3 Stocks To Watch Heading Into Tuesday ↗
U.S. stock futures up, Pfizer, Teradyne, Merck & Co., Palantir, and AMD expected to release earnings reports. Palantir and AMD beat estimates. 
Via Benzinga
News headline image
The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
As the pharmaceutical industry enters the heart of its Q4 2025 earnings season this February 2, 2026, a clear divide has emerged between the high-flying giants of the metabolic gold rush and those... 
Via MarketMinute
Topics Economy Government Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.